Short description
Verva Pharmaceuticals is a clinical-stage pharmaceutical company.
Description
Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined product portfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a significant unmet medical need.
Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
Total funding
$$2020202
Sign in for full access
Location
Southbank, Victoria, Australia, Oceania
Founded on
January 1, 2007
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Blurry Noaccess, Blurry Noaccess, Cannot Access
Sign in for full access